Jean‐Christophe Eymard

Randomized Phase II Trial of Everolimus in Combination With Tamoxifen in Patients With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer With Prior Exposure to Aromatase Inhibitors: A GINECO Study

Thomas Bachelot, C. Bourgier, Claire Cropet et al. · Journal of Clinical Oncology · 2012 · 709 citations · Full text

Medicine, Oncology, Pharmacology +17

Cabazitaxel versus Abiraterone or Enzalutamide in Metastatic Prostate Cancer

Ronald de Wit, Johann S. de Bono, Cora N. Sternberg et al. · New England Journal of Medicine · 2019 · 660 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

The New Combination Docetaxel, Prednisone and Curcumin in Patients with Castration-Resistant Prostate Cancer: A Pilot Phase II Study

Hakim Mahammedi, E. Planchat, Mélanie Pouget et al. · Oncology · 2016 · 138 citations

Medicine, Oncology, Pharmacology +17

Prognostic Factors for Survival in Noncastrate Metastatic Prostate Cancer: Validation of the Glass Model and Development of a Novel Simplified Prognostic Model

Gwénaëlle Gravis, Jean‐Marie Boher, Karim Fizazi et al. · European Urology · 2014 · 130 citations · Full text

Medicine, Oncology, Urology +14

Docetaxel reintroduction in patients with metastatic castration‐resistant docetaxel‐sensitive prostate cancer: a retrospective multicentre study

Jean‐Christophe Eymard, Stéphane Oudard, Gwénaëlle Gravis et al. · British Journal of Urology · 2010 · 96 citations

Medicine, Oncology, Pharmacology +16